Table 1. Correlation between the clinicopathological features and SENP3 expression.
| Characteristics | Case no. | Positivity area of SENP3 (%) | Non-parametric test value | P-value |
|---|---|---|---|---|
| Gender | ||||
| Male | 152 | 28.24±14.29 | Z=−0.604 | 0.546 |
| Female | 7 | 30.05±15.64 | ||
| Tobacco smoking* | ||||
| Yes | 117 | 29.81±14.41 | Z=−2.237 | 0.025 |
| No | 42 | 24.15±13.29 | ||
| Alcohol | ||||
| Yes | 25 | 33.35±14.87 | Z=−1.874 | 0.061 |
| No | 134 | 27.38±14.05 | ||
| Nodal status** | ||||
| N0 | 111 | 26.37±14.15 | Z=−2.735 | 0.006 |
| N1-2 | 48 | 32.83±13.74 | ||
| Pathological differentiation grade | ||||
| Well | 67 | 26.37±14.15 | X2=2.626 d.f.=2 | 0.269 |
| Moderate | 82 | 32.83±13.74 | ||
| Poor | 10 | 26.37±14.15 | ||
| Clinical stage (TNM classification)** | ||||
| I | 52 | 24.56±13.53 | X2=15.789 d.f.=3 | 0.001 |
| II | 39 | 23.86±9.375 | ||
| III | 43 | 32.07±15.74 | ||
| IV | 25 | 36.64±14.96 | ||
| Tumor stage* | ||||
| T1 | 52 | 24.56±13.53 | X2=10.407 d.f.=3 | 0.015 |
| T2 | 52 | 26.64±11.74 | ||
| T3 | 37 | 31.41±15.42 | ||
| T4 | 18 | 37.66±16.40 | ||
| Tumor site | ||||
| Supraglottic | 50 | 29.28±11.68 | X2=0.452 d.f.=2 | 0.798 |
| Glottic | 91 | 28.44±16.52 | ||
| Subglottic | 18 | 27.80±10.94 | ||
Abbreviations: d.f., degree of freedom; TNM, tumor, lymph node, metastasis. **P<0.01, *P<0.05.